DOCK8 is essential for LFA-1-dependent positioning of T follicular helper cells in germinal centers.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
06 08 2020
Historique:
received: 25 10 2019
accepted: 18 06 2020
pubmed: 24 6 2020
medline: 1 6 2021
entrez: 24 6 2020
Statut: epublish

Résumé

T follicular helper (Tfh) cell migration into germinal centers (GCs) is essential for the generation of GC B cells and antibody responses to T cell-dependent (TD) antigens. This process requires interactions between lymphocyte function-associated antigen 1 (LFA-1) on Tfh cells and ICAMs on B cells. The mechanisms underlying defective antibody responses to TD antigens in DOCK8 deficiency are incompletely understood. We show that mice selectively lacking DOCK8 in T cells had impaired IgG antibody responses to TD antigens, decreased GC size, and reduced numbers of GC B cells. However, they developed normal numbers of Tfh cells with intact capacity for driving B cell differentiation into a GC phenotype in vitro. Notably, migration of DOCK8-deficient T cells into GCs was defective. Following T cell receptor (TCR)/CD3 ligation, DOCK8-deficient T cells had impaired LFA-1 activation and reduced binding to ICAM-1. Our results therefore indicate that DOCK8 is important for LFA-1-dependent positioning of Tfh cells in GCs, and thereby the generation of GC B cells and IgG antibody responses to TD antigen.

Identifiants

pubmed: 32573493
pii: 134508
doi: 10.1172/jci.insight.134508
pmc: PMC7455063
doi:
pii:

Substances chimiques

Dock8 protein, mouse 0
Guanine Nucleotide Exchange Factors 0
Lymphocyte Function-Associated Antigen-1 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : K08 AI114968
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034854
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007627
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI114458
Pays : United States

Références

J Biol Chem. 2009 May 8;284(19):12645-53
pubmed: 19297325
Exp Parasitol. 2015 Nov;158:8-17
pubmed: 25728231
J Leukoc Biol. 2012 Oct;92(4):883-93
pubmed: 22798686
Immunity. 2011 Jun 24;34(6):947-60
pubmed: 21636295
Nat Rev Immunol. 2015 Mar;15(3):137-48
pubmed: 25656706
Nat Immunol. 2010 Jun;11(6):535-42
pubmed: 20453843
J Immunol. 2010 Jul 1;185(1):190-202
pubmed: 20525889
Cell Rep. 2018 Jan 23;22(4):979-991
pubmed: 29386139
Science. 2014 Aug 29;345(6200):1058-62
pubmed: 25170154
Hum Mol Genet. 2016 Feb 1;25(3):571-83
pubmed: 26647307
Immunity. 2016 Oct 18;45(4):831-846
pubmed: 27760339
Immunity. 2017 Dec 19;47(6):1142-1153.e4
pubmed: 29262350
J Exp Med. 2010 Feb 15;207(2):365-78
pubmed: 20142430
JCI Insight. 2017 Oct 5;2(19):
pubmed: 28978806
NPJ Vaccines. 2018 Oct 10;3:51
pubmed: 30323958
Curr Opin Immunol. 2017 Apr;45:21-30
pubmed: 28088708
Immunology. 2012 Oct;137(2):183-96
pubmed: 22804504
Eur J Immunol. 2017 Apr;47(4):677-684
pubmed: 28198542
J Immunol. 2006 Oct 1;177(7):4927-32
pubmed: 16982935
J Exp Med. 2008 Apr 14;205(4):869-82
pubmed: 18362170
J Exp Med. 2009 Jul 6;206(7):1485-93
pubmed: 19506051
J Immunol. 2006 Dec 1;177(11):7707-14
pubmed: 17114441
N Engl J Med. 2009 Nov 19;361(21):2046-55
pubmed: 19776401
Mol Biol Cell. 2013 Nov;24(21):3358-68
pubmed: 24006483
Immunity. 2011 Oct 28;35(4):622-32
pubmed: 22018472
J Immunol. 2012 Feb 1;188(3):1421-30
pubmed: 22219321
J Clin Invest. 2016 Oct 3;126(10):3837-3851
pubmed: 27599296
Methods Mol Biol. 2015;1291:151-60
pubmed: 25836309
J Allergy Clin Immunol. 2009 Dec;124(6):1289-302.e4
pubmed: 20004785
Immunity. 2011 Jun 24;34(6):961-72
pubmed: 21636294
Curr Opin Cell Biol. 2014 Oct;30:17-24
pubmed: 24907445
Nat Immunol. 2012 May 13;13(6):612-20
pubmed: 22581261
J Exp Med. 2000 Dec 4;192(11):1553-62
pubmed: 11104798
Nat Immunol. 2016 Oct;17(10):1197-1205
pubmed: 27573866
Nature. 2013 Apr 25;496(7446):523-7
pubmed: 23619696
J Exp Med. 2002 Dec 16;196(12):1645-51
pubmed: 12486107
Front Immunol. 2019 Apr 26;10:715
pubmed: 31105687
Eur J Immunol. 1997 Jan;27(1):35-9
pubmed: 9021995
Immunol Cell Biol. 2017 Jan;95(1):33-41
pubmed: 27465674
Immunity. 2011 Jun 24;34(6):932-46
pubmed: 21636296
Immunol Rev. 2019 Mar;288(1):37-48
pubmed: 30874355
Nat Immunol. 2009 Dec;10(12):1283-91
pubmed: 19898472
Nat Immunol. 2011 Feb;12(2):167-77
pubmed: 21217759
J Exp Med. 2017 Nov 6;214(11):3435-3448
pubmed: 28939548
Science. 2013 Aug 9;341(6146):673-7
pubmed: 23887872
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2097-103
pubmed: 22772752
Immunol Rev. 2019 Mar;288(1):85-96
pubmed: 30874350
J Exp Med. 2011 Oct 24;208(11):2305-20
pubmed: 22006977
Nat Immunol. 2009 Apr;10(4):385-93
pubmed: 19252490
Immunity. 1994 Aug;1(5):423-31
pubmed: 7882172
J Exp Med. 2000 Dec 4;192(11):1545-52
pubmed: 11104797
Trends Immunol. 2015 Jul;36(7):410-8
pubmed: 26091728
Immunity. 2010 Feb 26;32(2):253-65
pubmed: 20153220
J Exp Med. 1999 Oct 18;190(8):1123-34
pubmed: 10523610
J Exp Med. 2011 Jun 6;208(6):1243-52
pubmed: 21576382
Nature. 2008 Oct 9;455(7214):764-9
pubmed: 18843362
Genomics. 2001 Mar 1;72(2):128-36
pubmed: 11401425
Science. 1997 Apr 25;276(5312):589-92
pubmed: 9110977
Annu Rev Immunol. 1994;12:117-39
pubmed: 8011279
Bioarchitecture. 2012 Sep-Oct;2(5):158-70
pubmed: 22954512
J Immunol. 2013 Apr 1;190(7):3661-9
pubmed: 23455509
Nature. 1989 Oct 19;341(6243):619-24
pubmed: 2477710
Compr Physiol. 2012 Jul;2(3):1819-52
pubmed: 23723025
J Exp Med. 2009 May 11;206(5):1001-7
pubmed: 19380638
J Immunol. 1999 Apr 1;162(7):3749-52
pubmed: 10201887
Immunol Rev. 2017 Mar;276(1):112-120
pubmed: 28258695
J Exp Med. 2014 Jun 30;211(7):1297-305
pubmed: 24913235
J Immunol. 2008 Sep 15;181(6):3994-4003
pubmed: 18768854
J Interferon Cytokine Res. 2011 Jan;31(1):183-97
pubmed: 21166591
Cell. 2010 Nov 12;143(4):592-605
pubmed: 21074050
Trends Cell Biol. 2009 Feb;19(2):72-80
pubmed: 19144521
Front Immunol. 2017 Apr 28;8:489
pubmed: 28503175
Science. 2019 Aug 30;365(6456):
pubmed: 31371561

Auteurs

Erin Janssen (E)

Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Mira Tohme (M)

Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Jordan Butts (J)

Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Sophie Giguere (S)

Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard Medical School, Cambridge, Massachusetts, USA.

Peter T Sage (PT)

Transplantation Research Center, Renal Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Francisco E Velázquez (FE)

Center for Excellence in Vascular Biology, Brigham and Women's Hospital, Departments of Pathology and Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Christy Kam (C)

Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Elena Milin (E)

Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Mrinmoy Das (M)

Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Ali Sobh (A)

Department of Pediatrics, Mansoura University Children's Hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Salem Al-Tamemi (S)

Sultan Qaboos University Hospital, Muscat, Oman.

Francis W Luscinskas (FW)

Center for Excellence in Vascular Biology, Brigham and Women's Hospital, Departments of Pathology and Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Facundo Batista (F)

Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard Medical School, Cambridge, Massachusetts, USA.

Raif S Geha (RS)

Division of Immunology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH